TANC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.444600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.547400E-01
Normal-vs-Stage2
9.689400E-01
Normal-vs-Stage3
8.597800E-01
Normal-vs-Stage4
4.040000E-01
Stage1-vs-Stage2
4.403400E-01
Stage1-vs-Stage3
8.145800E-01
Stage1-vs-Stage4
1.377020E-01
Stage2-vs-Stage3
7.394600E-01
Stage2-vs-Stage4
2.483200E-01
Stage3-vs-Stage4
3.885000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.963800E-01
Normal-vs-AfricanAmerican
9.845400E-01
Normal-vs-Asian
7.676200E-01
Caucasian-vs-AfricanAmerican
8.732800E-01
Caucasian-vs-Asian
3.252600E-01
AfricanAmerican-vs-Asian
6.754400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.823400E-01
Normal-vs-Female
9.748400E-01
Male-vs-Female
4.920800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.012200E-01
Normal-vs-Age(41-60Yrs)
9.037200E-01
Normal-vs-Age(61-80Yrs)
9.360600E-01
Normal-vs-Age(81-100Yrs)
5.453200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.298600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.472200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.654800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.739200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.959030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.696200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.568600E-01
Normal-vs-Daily Drinker
5.823000E-01
Normal-vs-Weekly Drinker
6.608200E-01
Normal-vs-Occasional Drinker
9.780800E-01
Normal-vs-Social Drinker
9.308000E-01
Non Drinker-vs-Daily Drinker
4.196600E-01
Non Drinker-vs-Weekly Drinker
2.675200E-01
Non Drinker-vs-Occasional Drinker
6.749800E-01
Non Drinker-vs-Social Drinker
6.154200E-01
Daily Drinker-vs-Weekly Drinker
1.306010E-01
Daily Drinker-vs-Occasional Drinker
2.617400E-01
Daily Drinker-vs-Social Drinker
2.622600E-01
Weekly Drinker-vs-Occasional Drinker
3.959600E-01
Weekly Drinker-vs-Social Drinker
4.551800E-01
Occasional Drinker-vs-Social Drinker
9.064600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.268360E-01
Normal-vs-Grade 2
1.562260E-02
Normal-vs-Grade 3
1.138460E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.800800E-04
Grade 1-vs-Grade 3
3.082300E-03
Grade 1-vs-Grade 4
1.268360E-01
Grade 2-vs-Grade 3
6.155000E-01
Grade 2-vs-Grade 4
1.562260E-02
Grade 3-vs-Grade 4
1.138460E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.000600E-01
Normal-vs-NonDiabetic
9.964400E-01
Diabetic-vs-NonDiabetic
2.127400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.656600E-01
Normal-vs-NoPancreatitis
9.038800E-01
Pancreatitis-vs-NoPancreatitis
7.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.243400E-01
Normal-vs-N1
9.805600E-01
N0-vs-N1
3.691800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.329400E-01
Normal-vs-TP53-NonMutant
6.802400E-01
TP53-Mutant-vs-TP53-NonMutant
5.629000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
